PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Share-based Compensation (2021 - 2026)

PepGen (PEPG) posted Share-based Compensation of $2.9 million for Q1 2026, up 17.15% sequentially from $2.4 million in Q4 2025, and down 16.81% YoY from $3.4 million in Q1 2025.

Analysis

PepGen (PEPG) Share-based Compensation (2021 - 2026) Analysis & Trends

PepGen has reported Share-based Compensation for 6 years, with the latest figure at $2.9 million in Q1 2026.

  • Quarterly Share-based Compensation fell 16.81% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.1 million (down 13.73% YoY) and the FY2025 annual result came in at $15.8 million, down 46.8% from the prior year.
  • Share-based Compensation improved to $2.9 million in Q1 2026 per PEPG's latest filing, from $2.4 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $25.6 million in Q2 2025 and troughed at $815000.0 in Q1 2022.
  • A 5-year average of $4.8 million and a median of $2.4 million in 2025 frame the typical range for Share-based Compensation.
  • The sharpest annual moves came in 2022 and 2023: Share-based Compensation soared 3359.64% in 2022, then plunged 91.7% in 2023.
  • Over 5 years, Share-based Compensation stood at $23.1 million in 2022, then slumped by 91.7% to $1.9 million in 2023, then soared by 74.14% to $3.3 million in 2024, then fell by 27.19% to $2.4 million in 2025, then rose by 17.15% to $2.9 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $2.9 million, $2.4 million, and $2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 PepGen 217.99 Mn 217.99 Mn - 20.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.40 Mn
Mar 31, 2026 24.10 Mn
Dec 31, 2025 2.44 Mn
Sep 30, 2025 14.50 Mn
Jun 30, 2025 6.62 Mn
Mar 31, 2025 6.76 Mn
Dec 31, 2024 3.35 Mn
Sep 30, 2024 5.67 Mn
Jun 30, 2024 5.28 Mn
Mar 31, 2024 5.28 Mn
Dec 31, 2023 1.92 Mn
Sep 30, 2023 4.17 Mn
Jun 30, 2023 4.22 Mn
Mar 31, 2023 1.35 Mn
Dec 31, 2022 23.15 Mn
Sep 30, 2022 3.37 Mn
Jun 30, 2022 3.21 Mn
Mar 31, 2022 2.08 Mn
Dec 31, 2021 669,000.00
Sep 30, 2021 348,000.00